Navigation Links
New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal
Date:5/26/2009

ailable full prescribing information for tapentadol at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022304s000lbl_v2.pdf

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Johnson & Johnson Pharmaceutical Research & Development, L.L.C., (J&JPRD) is a wholly owned subsidiary of Johnson & Johnson, the world's most broadly based producer of health care products. J&JPRD is headquartered in Raritan, N.J., and has facilities throughout Europe, the United States and Asia. J&JPRD is leveraging drug discovery and drug development in a variety of therapeutic areas, including CNS, Internal Medicine and Oncology, to address unmet medical needs worldwide. More information can be found at http://www.jnjpharmarnd.com/.

PriCara,(R) Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

PriCara,(R), Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., is a major health care company in the United States dedicated to the needs of primary care providers who serve a vital role on the frontline of medicine. For more information about the company, please visit www.PriCara.com.

Grunenthal

Grunenthal, a privately owned pharmaceutical company based in Aachen, Germany, discovered and started development of tapentadol. Grunenthal and J&JPRD have shared development responsibilities for tapentadol for acute and chronic pain conditions since the companies signed a licensing agreement for tapentadol in 2003.

Grunenthal licensed marketing rights to tapentadol to Ortho-McNeil-Janssen Pharmaceuticals, Inc. for the United States, Canada and Japan. Grunenthal maintains marketing rights in Europe and other parts o
'/>"/>

SOURCE Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Dainippon Sumitomo Pharma Announces Lurasidone Phase III Data in Patients With Schizophrenia
2. Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)
3. Essentialis Meets Primary Endpoint in Phase 2b Trial of DCCR for Treatment of Hypertriglyceridemia and is Granted Extensive Patent Coverage in the US
4. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
5. BioVex to Report Phase I/II Clinical Trial Results for the Front Line Treatment of Head and Neck Cancer With OncoVEX GM-CSF at the 2009 American Society of Clinical Oncology Meeting
6. Novavax Completes Enrollment of Its Second Phase II Seasonal Influenza VLP Vaccine Clinical Trial
7. Pixantrone Phase 3 Data to be Presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting
8. Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009
9. Metabolic Solutions Development Company Announces Preliminary Results from Phase IIa Clinical Trial
10. Medarex Announces Primary Endpoint Achieved in MDX-1100 Anti-IP-10 Antibody Phase 2 Trial for Rheumatoid Arthritis
11. Circassia Begins Phase II Clinical Trial With Ragweed Allergy Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... , April 21, 2015 Cardiologists at Henry Ford ... stroke in patients with an irregular heartbeat. With ... Henry Ford is able to add another option ... fibrillation, which affects the heart,s ability to pump. ... and first-ever commercial Watchman implant at a non-clinical trial ...
(Date:4/21/2015)... -- According to a new market ... Blood, Gene Therapy), Product (Instruments, Services, Kits, Reagents), ... Contamination, Adventitious Agents) - Global Forecast to 2019", ... Market was valued at $1,758.69 Million in 2014. ... CAGR of 12.23% to reach $3,130.85 Million in ...
(Date:4/21/2015)... -- Seattle Children,s announced today that 20 of 22 ... genetically reprogrammed T cells to treat relapsed acute lymphoblastic ... sensitive tests designed to detect minute amounts of cancer ... included children with very high tumor burdens as well ... "These results are extremely encouraging," said ...
Breaking Medicine Technology:Stroke Risk Caused by Abnormal Heart Rhythm Reduced Without Blood Thinners 2Stroke Risk Caused by Abnormal Heart Rhythm Reduced Without Blood Thinners 3Biologics Safety Testing Market Worth $3,130.85 Million by 2019 2Biologics Safety Testing Market Worth $3,130.85 Million by 2019 3Biologics Safety Testing Market Worth $3,130.85 Million by 2019 4Seattle Children's Pediatric Leukemia Adoptive Therapy (PLAT-02) Clinical Trial Boasts 91% Complete Remission Rate in Children with Relapsed Leukemia 2Seattle Children's Pediatric Leukemia Adoptive Therapy (PLAT-02) Clinical Trial Boasts 91% Complete Remission Rate in Children with Relapsed Leukemia 3
(Date:4/21/2015)... 2015 Dr. Aaron Choroomi, dentist in ... are now offering a valuable discount on restorative dental implants. ... promotional price of only $1695 for a limited time. This ... for a limited time. , "There are times that ... the price," dental implants dentist , Dr. Choroomi, stated. ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 Zane Benefits, ... businesses, announced today the publication of a new guide ... reform brought changes to the health insurance industry, including ... business owners to question what is permitted when implementing ... small business owners determine which HRAs are compliant this ...
(Date:4/21/2015)... 2015 Le Petit Retreat Day Spa in ... today in the leafy, historic Larchmont neighborhood, newly renamed as ... new theme of “Disconnect to Reconnect.” Tina Figueroa, a ... award-winning day spa, announces the new name and new vision ... offerings that help celebrate connections with Moms and their adult ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 Zane Benefits, ... announced today its CEO Rick Lindquist has been selected ... 2015. , According to Rick Lindquist, “There is a ... and Zane Benefits’ small business solutions are at its ... provided by Employee Benefit Adviser’s Rising Stars.” , According ...
(Date:4/21/2015)... April 21, 2015 Carinsurancesavings.biz has released a ... under proper surveillance and explaining the impact on a ... vehicles safe and supervised may be eligible for advantageous auto ... in a simple and efficient way. This will also help ... convenient and simple way. , Finding low cost coverage is ...
Breaking Medicine News(10 mins):Health News:101 Dental Group is Now Offering a Promotion on Dental Implants 2Health News:Larchmont Sanctuary Spa Revealed as New Name For Neighborhood Spa; New Owner, New Eco Offerings & New Theme: “Disconnect to Reconnect” 2Health News:Larchmont Sanctuary Spa Revealed as New Name For Neighborhood Spa; New Owner, New Eco Offerings & New Theme: “Disconnect to Reconnect” 3Health News:Zane Benefits’ CEO Named Top 20 Rising Stars 2Health News:Auto Insurance Quotes Offer Excellent Security for A Car 2
... in Reducing Infections for Patients in Intensive Care , ... in southeast Pennsylvania have successfully reduced or eliminated healthcare-associated ... and are featured in the Pennsylvania Patient Safety Authority,s ... Patients in intensive care are at high risk for ...
... to Vaccinate 1.2 Million Americans - , , ... Caremark,s retail clinic division, have received the National Influenza ... Campaign. The award, co-sponsored by the American Medical ... was presented yesterday evening in Dallas as health care ...
... Physicians Association (RPA) supports Kidney Care Partners (KCP) recently ... initiative. RPA is a member of KCP, a coalition ... and nurses who work together to improve quality care ... PEAK campaign is to reduce first-year dialysis patient mortality ...
... ... estimated 15-20 million American women, sex hurts. Most suffer in silence because they ... stinging, or stabbing pain in the genital area, urinary urgency, irritable bowel, low ... or enjoying, sex. For the first time, a new book brings this taboo ...
... Amsterdam, The Netherlands: Women with cystic fibrosis can have ... long-term adverse effects on either themselves or their children, ... meeting of the European Society of Human Reproduction and ... cystic fibrosis (CF) was a death sentence and most ...
... have a diminished number of eggs in their ovaries, either ... as ovarian surgery, may be more at risk of a ... normal, fertile range. Trisomic pregnancies occur when the embryo ... two. The most common trisomy is Down,s syndrome or trisomy ...
Cached Medicine News:Health News:Pennsylvania Patient Safety Authority Releases June Advisory 2Health News:Pennsylvania Patient Safety Authority Releases June Advisory 3Health News:Pennsylvania Patient Safety Authority Releases June Advisory 4Health News:Pennsylvania Patient Safety Authority Releases June Advisory 5Health News:CVS/pharmacy and MinuteClinic Receive Award of Excellence from National Influenza Vaccine Summit 2Health News:CVS/pharmacy and MinuteClinic Receive Award of Excellence from National Influenza Vaccine Summit 3Health News:First Book Focusing on How "The Secret Pain Women Won't Talk About" Affects Relationships 2Health News:First Book Focusing on How "The Secret Pain Women Won't Talk About" Affects Relationships 3Health News:First Book Focusing on How "The Secret Pain Women Won't Talk About" Affects Relationships 4Health News:Women with cystic fibrosis can have safe and successful fertility treatment 2Health News:Women with cystic fibrosis can have safe and successful fertility treatment 3Health News:Reduced ovarian reserve associated with increased risk of trisomic pregnancy 2Health News:Reduced ovarian reserve associated with increased risk of trisomic pregnancy 3
... Nidek GYC-1000 delivers a solid-state ... of energy and plugs into ... compact design and extreme portability, ... with the Nidek Phaco Emulsification ...
There are many reasons to choose the CardioGenesis 2000 Holmium:YAG Laser System for TMR in your hospital or medical facility. Among the first is the CardioGenesis commitment to deliver the highest q...
Total T3 EIA Thyroid Function 025-BC-1005...
... The anti-TG test kit is a solid ... format. It is designed for the quantitative ... (TG) in serum or plasma. The microplate ... Calibrators, controls and patient samples are pipetted ...
Medicine Products: